Together they stay alive longer

June 12, 2020

Hamburg/Borstel/Leipzig. The tuberculosis pathogen Mycobacterium tuberculosis can protect itself better when combined and thus stay alive longer in the air. This was the result of a study by the Leibniz Research Alliance INFECTIONS, which was published in the scientific journal Scientific Reports on Monday.

The study examined the biophysical properties of tiny particles in the air (aerosols) that contribute to the spread of the pathogen. A successful human-to-human infection is determined, among other things, by the distance that the pathogen can travel through the air before the infectivity decreases. Conclusion: Although individual mycobacteria form smaller aerosols and can thus travel longer distances in the air, interconnected mycobacteria remain alive for longer. The study is based on earlier results that showed that mycobacteria-infected host cells die necrotic cell death, as occurs in the lungs of tuberculosis patients. It has now been shown that larger aerosol particles from mycobacterial clusters are produced together with components of the dead cells, which are more viable in the air than individual bacteria. Based on these data, computer simulations of airborne dispersal, which take into account the particle size distribution, can be carried out in the future, which will help to find out which aerosol composition may pose an increased risk of infection for humans.

The study was carried out at the Research Center Borstel, Leibniz Lung Center (FZB) in Schleswig-Holstein and the Heinrich Pette Institute (HPI), Leibniz Institute for Experimental Virology in Hamburg. The Leibniz Institute for Tropospheric Research (TROPOS) contributed its expertise in modelling the dispersion of aerosols such as mycobacterial associations floating in the air to the study.

Currently there is a controversial discussion about the importance of the aerosol dispersion of the SARS-CoV-2 virus for the COVID-19 pandemic. Findings on the aerosol spread of pathogens are therefore of particular interest. Whether parts of the new findings on the tuberculosis pathogen can be transferred to the COVID-19 pathogen is, however, currently completely open, since tuberculosis is transmitted by a bacterium that is significantly larger than the SARS-CoV-2 virus. Viruses are considered to be much more sensitive to environmental influences, as they depend on protection by moisture and dry out relatively quickly.

E. Pfrommer, C. Dreier, G. Gabriel, T. Dallenga, R. Reimer, K. Schepanski, R. Schreließ, U. E. Schaible, T. Gutsmann (2020): Enhanced tenacity of mycobacterial aerosols from necrotic neutrophils. Scientific Reports 10, Article number: 9159 (2020).

Links Leibniz Research Alliance INFECTIONS:

Scientific contact persons

Prof. Dr. Ulrich Schaible
Research Center Borstel - Leibniz Lung Center
Phone +49-4537 - 188 600

Contact on TROPOS:

Dr. Kerstin Schepanski
Scientific staff, TROPOS Department Modelling of Atmospheric Processes
Leibniz Institute for Tropospheric Research
Tel.: +49 341 2717-7195

Leibniz Institute for Tropospheric Research (TROPOS)

Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to